Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from NYSE

Walmart And 3 Other Stocks Sold By Insiders

Although gold futures traded lower on Monday, there were a few notable insider trades.

Benzinga

Looking At Goldman Sachs Group's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Goldman Sachs Group (NYSE:GS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Why This Citigroup Analyst Is Turning Bearish: 'Higher Tail Risks'

Citigroup Inc’s (NYSE: C) prospects have been hurt by the lack of near-term catalysts and the negative impact of de-globalization, according to Morgan Stanley.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Hycroft Mining Was 'Exactly Like AMC A Year Ago': AMC CEO Explains Miner Acquisition

At first glance, it seems quite peculiar, but AMC Entertainment Holdings Inc's (NYSE: AMC) recent investment in Hycroft Mining Holding Corp (NASDAQ: HYMC) makes more sense below the surface.

Benzinga

Walmart Ends Cigarette Sales In Some Markets: Report

Walmart Inc. (NYSE: WMT) is removing cigarettes from its stores in several states following a long-running debate on whether to ban tobacco products from being sold.

Benzinga

Why Bank Analyst Is Bullish On Citigroup Following CFO Meeting

Citigroup Inc (NYSE: C) shares have lagged the S&P 500 and many of its banking peers so far in 2022, but Bank of America analyst Ebrahim Poonawala said Monday that a recent meeting with Citigroup CFO Mark Mason has him feeling extremely optimistic about the stock's outlo

Benzinga

Earnings Outlook For PVH

PVH (NYSE:PVH) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that PVH will report an earnings per share (EPS) of $2.00.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview For Chewy

Chewy (NYSE:CHWY) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Chewy will report an earnings per share (EPS) of $-0.08.

Benzinga

Mosaic Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Mosaic (NYSE:MOS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Expert Ratings For Regions Financial

Analysts have provided the following ratings for Regions Financial (NYSE:RF) within the last quarter:

Benzinga

Where Truist Financial Stands With Analysts

Within the last quarter, Truist Financial (NYSE:TFC) has observed the following analyst ratings:

Benzinga

If You Invested $1000 In GameStop 15 Years Ago, Here's How Much You Would Have Today

GameStop (NYSE:GME) has outperformed the market over the past 15 years by 3.25% on an annualized basis producing an average annual return of 11.2%. Currently, GameStop has a market capitalization of $12.41 billion.

Benzinga

Plantronics And HP? Why POLY Shares Are Soaring

Plantronics Inc (NYSE: POLY) is trading significantly higher Monday after HP Inc (NYSE: HPQ) announced it will acquire the company.

Benzinga

Here's Why AMC Shares Are Popping Off

AMC Entertainment Holdings Inc (NYSE: AMC) shares are trading higher by 15.5% at $23.38 after the company's CEO Adam Aron discussed potential future investments to capitalize on the interest of retail investors.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

A Bearish Sign Appears On Lincoln National's Chart

If history is any guide, there may be trouble ahead for shares of Lincoln National (NYSE:LNC). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

A Bearish Sign Appears On Jones Lang LaSalle's Chart

If history is any guide, there may be trouble ahead for shares of Jones Lang LaSalle (NYSE:JLL). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

A Bearish Sign Appears On Advance Auto Parts's Chart

If history is any guide, there may be trouble ahead for shares of Advance Auto Parts (NYSE:AAP). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Granite Point Mortgage's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Granite Point Mortgage (NYSE:GPMT).

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Urstadt Biddle Properties's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Urstadt Biddle Properties (NYSE:UBP).

Benzinga

Ralph Lauren's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Ralph Lauren (NYSE:RL).

Benzinga

Servisfirst Bancshares's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Wednesday marks the last chance for investors to receive the next dividend payout from Servisfirst Bancshares (NYSE:SFBS).

Benzinga

5 Value Stocks In The Real Estate Sector

What are Value Stocks?

Benzinga

Check Out What Whales Are Doing With WFC

A whale with a lot of money to spend has taken a noticeably bearish stance on Wells Fargo. Looking at options history for Wells Fargo (NYSE:WFC) we detected 16 strange trades.

Benzinga

Mid-Morning Market Update: Markets Mixed; SAIC Profit Tops Views

U.S. stocks traded mixed this morning, with the Dow dropping around 100 points on Monday.

Benzinga

FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron Subvariant

The FDA said that the currently authorized 500mg dose of GlaxoSmithKline Plc (NYSE:GSK) and Vir Biotechnology Inc's (NASDAQ:VIR) COVID-19 antibody therapy is unlikely to be effective against the omicron BA.2 variant. The agency updated its website to exclude sotrovimab use in geographic regions where the infection is likely caused by the omicron BA.2 variant. GSK…

1 … 450 451 452 453

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.